Deutsche Bank
MBX

Deutsche Bank’s MBX Biosciences MBX Stock Holding History

Deutsche Bank’s Portfolio MBX Stock Details MBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$685K Buy
22,950
+2,923
+15% +$99.4K ﹤0.01% 2409
2025
Q4 		$632K Buy
20,027
+9,104
+83% +$221K ﹤0.01% 2448
2025
Q3 		$191K Buy
10,923
+2,161
+25% +$28.9K ﹤0.01% 3084
2025
Q2 		$100K Hold
8,762
– – ﹤0.01% 3257
2025
Q1 		$64.7K Buy
8,762
+4,424
+102% +$46.8K ﹤0.01% 3319
2024
Q4 		$79.9K Buy
+4,338
New +$92.5K ﹤0.01% 3347

Other funds holding MBX

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
NA
NVP Associates Menlo Park, California $176M AUM 208.78% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Deutsche Bank's MBX Position: Q1 2026 in Review

Deutsche Bank increased its MBX Biosciences (MBX) stake by 15% in Q1 2026, buying an estimated $99.4K and bringing the position to 22,950 shares worth $685K. The position accounts for ﹤0.01% of the portfolio, ranked #2409.

Deutsche Bank first reported a position in MBX in Q4 2024 and has held it in 6 quarters since. 157 funds tracked by Wall St. Rank hold MBX as of Q1 2026.

  • Deutsche Bank held 22,950 shares of MBX Biosciences worth $685K as of Q1 2026.
  • Deutsche Bank bought 2,923 MBX Biosciences shares in Q1 2026, an estimated $99.4K.
  • MBX Biosciences made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #2409 holding.
  • Deutsche Bank first reported a position in MBX Biosciences in Q4 2024 and has held it in 6 quarters since.
  • 157 funds tracked by Wall St. Rank held MBX Biosciences as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.